As the Ki–67 proliferation index has demonstrated efficacy in predicting oncologic outcomes following chemotherapy [4,17,18,19], we hypothesized that it may have some utility in predicting changes in tumor size following treatment with NET. The gene discussed is MKI67; the disease is neoplasm.